BridgeMD
New treatment option for Menstruation Disturbances
Official title Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
ClinicalTrials.gov ID: NCT07083635
What this study is testing
What is Transdermal Ethinyl Estradiol/Norelgestromin Patch?
Transdermal Ethinyl Estradiol/Norelgestromin Patch is an investigational medicine, being studied as a potential treatment for menstruation disturbances.
Also referred to as Ethinyl Estradiol and Norelgestromin Transdermal Patch, Transdermal Contraceptive Patch.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to evaluate the effectiveness of transdermal contraceptive patches in treating irregular vaginal bleeding in women over 18 years old who are using contraceptive implants and experiencing abnormal vaginal bleeding. The main questions it aims to answer are: Does transdermal ethinyl estradiol and norelgestromin patch effectively treat irregular vaginal bleeding caused by contraceptive implants compared to placebo?
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women aged 18 years and older
- Regular menstrual cycles : at least 1 cycle prior to contraceptive implant insertion
- Normal pelvic examination and transvaginal ultrasound results
- Normal cervical cancer screening within the past 3 years
- Irregular vaginal bleeding defined as: Bleeding for more than 8 consecutive days, or Bleeding-free intervals of 15 days or less
You likely can't join if
- Previous treatment for irregular vaginal bleeding within the past 3 months
- Pregnancy
- Contraindications to estrogen or progestin use
- Allergy to estrogen or progestin
- Allergy to hormonal patches
- Heavy vaginal bleeding causing anemia symptoms such as: Fatigue/Fainting/Dizziness
The study team makes the final eligibility decision.
Where it's taking place
- Pathum Wan, Bangkok, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pathum Wan, Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.